UnitedHealth Group Incorporated
HealthcareNYSE:UNH · New York Stock Exchange
+$2.38 today
Vol 3.74M · Avg 8.25M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
12.8%
avg 21.0%
ROIC
8.2%
avg 12.1%
ROA
3.9%
avg 6.9%
Analysis
ROE is currently the strongest return metric at 12.8% versus its period average of 21.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Heather Rachelle Cianfrocco | EVice President of Governance, Compliance & Information Security | $3.45M | — | 52 | $22,438.32 | <0.01% |
Timothy John Noel | Chief Executive Officer of UnitedHealthcare Business | $3.20M | — | 54 | $7,369.00 | <0.01% |
Wayne Scott DeVeydt | Chief Financial Officer | $3.08M | — | 56 | $446.00 | <0.01% |
Patrick Hugh Conway | Chief Executive Officer of Optum | $2.92M | — | 51 | $16,914.31 | <0.01% |
Christopher R. Zaetta | Executive Vice President, Chief Legal Officer & Corporate Secretary | $1.79M | — | 54 | $16,582.15 | <0.01% |
Erin L. McSweeney | Executive Vice President & Chief People Officer | $1.77M | — | 61 | $15,552.92 | <0.01% |
Stephen J. Hemsley | Chief Executive Officer & Non-Independent Non-Executive Chairman | $1.28M | — | 73 | $362,628.94 | 0.04% |
Dennis Stankiewicz | Chief Accounting Officer & Corporate Controller | — | — | 48 | $10,205.94 | <0.01% |
Sandeep Dadlani | Executive Vice President and Chief Digital & Technology Officer | — | — | 51 | — | — |
Zachary William Sopcak | Senior Vice President of Capital Markets Communications & Investor Relations | — | — | — | $15,162.00 | <0.01% |
Richard J. Migliori | Executive Vice President & Senior Advisor | — | — | 69 | $1.22M | 0.13% |
Terry Clark | Executive Vice President & Chief Marketing Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
2
$293,613.35
Net Sentiment
$293,613.35
Net selling
Most Active
Conway Patrick Hugh
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Conway Patrick Hugh Direct | Sell | 800 | $355.00 | $284,000.00 | |
| Sep 11, 2025 | Baker Charles D. Indirect | Sell | 27 | $356.05 | $9,613.35 |
Analysis
Insiders reported 0 buys worth $0.00 and 2 sells worth $293,613.35 over the last 12 months. That adds up to net selling of $293,613.35. Conway Patrick Hugh was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +4.4% | +12.3% (15yr)4 analysts |
| Revenue | N/A | N/A | +12.4% | +8.7% (15yr)15 analysts |
| Net Income | N/A | N/A | +1.7% | +11.9% (15yr)15 analysts |
| EBIT | N/A | N/A | +6.0% | +8.9% (15yr)15 analysts |
Analysis
Recent growth has been strongest in Revenue at +12.4% over three years. Forward estimates point to EPS at +12.3% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Merck & Co., Inc.
NYSE:MRK
$296.38B
Novartis AG
NYSE:NVS
$292.82B
AstraZeneca PLC
NYSE:AZN
$278.78B
Novo Nordisk A/S
NYSE:NVO
$196.35B
Thermo Fisher Scientific Inc.
NYSE:TMO
$174.61B
Abbott Laboratories
NYSE:ABT
$152.98B
CVS Health Corporation
NYSE:CVS
$129.96B
Elevance Health Inc.
NYSE:ELV
$87.35B
Cigna Corporation
NYSE:CI
$78.87B
Humana Inc.
NYSE:HUM
$45.34B
Who manages UNH?
UnitedHealth Group Incorporated (UNH) lists 12 active executives. The top listed executive is Stephen J. Hemsley, Chief Executive Officer & Non-Independent Non-Executive Chairman.
Are UNH insiders buying or selling?
Recent insider activity shows net buying of $278.96M.
Explore More
Continue the stock analysis
Jump to another research area for this company.